Latest Regulatory Risk News

Vertex Minerals’ Reward Gold Mine produced 679 ounces in its first production year, but the transition came with a A$16.4 million loss, negative operating cash flow and a formal going-concern warning. The company now faces a narrow window to prove its mechanised mining plan can lift production before debt repayments and further funding decisions bite.

Port of Tauranga’s Stella Passage development has been hit by an appeal and a judicial review application from tangata whenua parties. The port says the project remains urgent and will seek the earliest possible court hearing, but has disclosed no estimate of the legal or financial impact.

Investor Centre’s FY2025 report lays bare the financial strain behind its proposed revival: revenue collapsed, cash fell to just $3,320 and liabilities exceeded assets by $3.81 million. The company is now relying on an unsecured Lake Volta Investments facility and a non-binding restructuring plan after its brokerage subsidiary lost its AFSL.

Clarity Pharmaceuticals is approaching pivotal Phase III readouts for its prostate cancer imaging agent, backed by AUD178.3 million in liquid assets. The radiopharmaceutical developer remains deeply loss-making, but expanded manufacturing capacity and early clinical signals are pulling its commercial ambitions into sharper focus.

Atlas Arteria has warned that France may more than double the tax rate applied to eligible toll-road operators, with APRR’s 2025 TEILD bill already reaching €126.7 million. The proposed changes remain subject to parliamentary debate and could be softened before becoming law.

Cobalt Blue has secured a US$150,000 contract to deliver key technical work for Glomar Minerals’ planned US polymetallic nodule refinery. The work takes Project Infinity into a formal Preliminary Economic Analysis, although the project remains at an early evaluation stage and its cost estimates carry a wide accuracy range.

Dimerix has secured Mexican composition of matter protection for its Phase 2-ready kidney drug DMX-652 until June 2041. The grant expands the asset’s patent estate ahead of planned clinical testing in acute kidney injury, although it brings no new clinical data or regulatory approval.

Elixinol Wellness has finalized the divestment of its US operations to Ananda Health, securing upfront and deferred payments totaling approximately A$465,000. This move refocuses the company on its Australian health and wellness portfolio while reducing exposure to US regulatory risks.

Klevo Group Limited (ASX:KLV) has announced a pro-rata entitlement issue of Loyalty Options to raise approximately $3.1 million, aiming to accelerate its credit capabilities and expand its Mastercard program in Asia.

Advance ZincTek posted an 11% rise in FY26 profit before tax to $2.247 million on 12.6% higher sales, driven by AI integration and US market strength. The company is set to enter residential battery manufacturing in FY27, leveraging its zinc oxide expertise.

Hawk Resources has cleared a major regulatory hurdle with the WA Minister for Aboriginal Affairs approving a Mining Entry Permit for its Olympus scandium project, paving the way for exploration activities to begin by September 2026, pending final government consents.

Magellan Infrastructure Fund (Currency Hedged) reported a $73.9 million profit for FY2026, down from $108.1 million the prior year, while boosting distributions to unitholders by over 270%.